Atezolizumab w/ enzalutamide did not improve survival vs enzalutamide in patients w/ metastatic castration-resistant prostate cancer who progressed on abiraterone. Genomic & immune biomarkers may identify those who benefit. ProstateCancerAwarenessMonth
T.P. received honoraria from advisory/consultancy roles with AstraZeneca, BMS, Exelixis, Incyte, Ipsen, Merck, MSD, Novartis, Pfizer, Seattle Genetics, Merck Serono , Astellas, Johnson & Johnson, Eisai and Roche; institutional research funding support from AstraZeneca, Roche, BMS, Exelixis, Ipsen, Merck, MSD, Novartis, Pfizer, Seattle Genetics, Merck Serono , Astellas and Johnson & Johnson; and travel, accommodation and expenses support from Roche, Pfizer, MSD, AstraZeneca and Ipsen. S.
received honoraria from Astellas Pharma, Janssen and Sanofi; received advisory/consultancy fees from Amgen, Astellas Pharma, AstraZeneca, Bayer, CureVac, ESSA Pharma, Janssen Oncology, Orion Pharma, Roche/Genentech and Sanofi; and travel, accommodations and expenses support from Amgen and Janssen. J.M.P.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Shannon Sharpe reveals he privately battled prostate cancerShannon Sharpe revealed he privately battled prostate cancer and is currently in remission.
Weiterlesen »
Hall of Famer Shannon Sharpe reveals 2016 prostate cancer diagnosis, says he 'cancer-free' nowFormer Broncos TE, current Fox Sports analyst revealed that he privately fought prostate cancer six years ago and that right now he is 'cancer-free.'
Weiterlesen »
Shannon Sharpe Reveals 2016 Prostate Cancer Diagnosis, Says He's Now Cancer-FreeHall of Famer Shannon Sharpe shared that he privately fought prostate cancer after being diagnosed in 2016 and said screening early “possibly saved my life.”
Weiterlesen »
NFL Hall of Famer Shannon Sharpe reveals prostate cancer diagnosis, says he's cancer-free nowNFL Hall of Famer Shannon Sharpe was diagnosed with prostrate cancer, but is now in remission. Sharpe revealed the diagnosis on Fox's pregame show, and said early detection may have saved his life.
Weiterlesen »
How to improve the diagnosis of prostate cancerProstate-specific antigen is an established biomarker, but it is flawed. Research into alternatives is starting to get results, but will they reduce mortality?
Weiterlesen »
Researchers take on the challenge of prostate cancerFresh treatment options along with kinder and more accurate diagnostics promise to improve care for prostate cancer
Weiterlesen »